Key result
Future directions of drug-eluting stents include specialized stent platforms, fully degradable stents, and the potential use of stents to prevent cardiac events.
This review highlights future directions for drug-eluting stents, including specialized platforms, fully degradable stents, and their potential to prevent cardiac events.
Coronary artery stents have changed the face of interventional cardiology since their introduction in 1986. The commercial release of drug‐eluting stents in 2002 promised to abolish in‐stent restenosis as the predominant clinical limitation following stent implantation. Concerns raised about increased risks of adverse events with drug‐eluting stents now appear unfounded but have heralded a new era of research, where only hard clinical end‐points in sufficiently large numbers of patients are considered adequate. In this review, we highlight some of the potential future directions of drug‐eluting stents including specialized stent platforms (including dedicated bifurcation stents), fully degradable stents, and the potential use of stents to prevent cardiac events.
No takes yet. Share an insight, caveat, or question.
Kukreja et al. (2009) conducted a review in Coronary artery disease. Drug-eluting stents was evaluated. Future directions of drug-eluting stents include specialized stent platforms, fully degradable stents, and the potential use of stents to prevent cardiac events.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: